Patent Infringement and Experimental Use Under the Hatch-Waxman Act : Current Issues.

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service. Resources, Science, and Industry Division.

Language:

English

Subjects (All):

Appellate procedure.

Judge-made law.

Drugs.

Medical economics.

Physical Description:

1 online resource (1 online resource (12 p), digital, PDF file)

monochrome

Place of Publication:

[Place of publication not identified] : [publisher not identified], 2012.

System Details:

text file

Summary:

Discusses current issues related to patent infringement provisions of the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products to accelerate generic drug approval process; and outlines basics of Hatch-Waxman patent dispute resolution system. Describes recent holding of U.S. Court of Appeals for the Federal Circuit in Classen Immunotherapies LLC v. Biogen Idec that limits statutory safe harbor to activities performed prior to FDA approval. Considers judicial developments regarding patent infringement provision of the Hatch-Waxman Act, and reviews pertinent legislative issues.

Notes:

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Apr. 2014). Reuse except for individual research requires license from ProQuest, LLC.

CRS Report.

Other Format:

Microfiche version: Library of Congress. Congressional Research Service. Resources, Science, and Industry Division. Patent Infringement and Experimental Use Under the Hatch-Waxman Act

Access Restriction:

Restricted for use by site license.